GB2371748B - HMG-COA reductase inhibitor extended release formulation - Google Patents
HMG-COA reductase inhibitor extended release formulationInfo
- Publication number
- GB2371748B GB2371748B GB0210619A GB0210619A GB2371748B GB 2371748 B GB2371748 B GB 2371748B GB 0210619 A GB0210619 A GB 0210619A GB 0210619 A GB0210619 A GB 0210619A GB 2371748 B GB2371748 B GB 2371748B
- Authority
- GB
- United Kingdom
- Prior art keywords
- hmg
- coa reductase
- release formulation
- extended release
- reductase inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43557699A | 1999-11-08 | 1999-11-08 | |
PCT/US2000/030415 WO2001034123A1 (en) | 1999-11-08 | 2000-11-03 | Hmg-coa reductase inhibitor extended release formulation |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0210619D0 GB0210619D0 (en) | 2002-06-19 |
GB2371748A GB2371748A (en) | 2002-08-07 |
GB2371748B true GB2371748B (en) | 2004-12-01 |
Family
ID=23728948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0210619A Expired - Lifetime GB2371748B (en) | 1999-11-08 | 2000-11-03 | HMG-COA reductase inhibitor extended release formulation |
Country Status (8)
Country | Link |
---|---|
AU (1) | AU768950B2 (en) |
CA (1) | CA2390301A1 (en) |
DE (1) | DE10085183T1 (en) |
GB (1) | GB2371748B (en) |
HK (1) | HK1050134A1 (en) |
IL (1) | IL149524A0 (en) |
NZ (1) | NZ518770A (en) |
WO (1) | WO2001034123A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050089572A1 (en) * | 2002-03-22 | 2005-04-28 | Manoj Kumar | Controlled release drug delivery system of pravastatin |
PL375411A1 (en) * | 2002-09-03 | 2005-11-28 | Biovail Laboratories, Inc. | Pharmaceuticals formulations and methods for modified release of statin drugs |
US20090196889A1 (en) * | 2004-11-22 | 2009-08-06 | Dexcel Pharma Technologies Ltd. | Controlled absorption of statins in the intestine |
WO2008044236A2 (en) * | 2006-10-10 | 2008-04-17 | Dexcel Pharma Technologies Ltd. | Improved release of statins in the intestine |
US9289418B2 (en) | 2013-03-15 | 2016-03-22 | Cedars-Sinai Medical Center | Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens |
AU2014239164B2 (en) | 2013-03-15 | 2018-12-06 | Cedars-Sinai Medical Center | Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens |
RU2697851C2 (en) | 2014-08-13 | 2019-08-21 | Седарс-Синаи Медикал Сентер | Antimetanogenic compositions and use thereof |
EP3277274B1 (en) | 2015-04-01 | 2024-06-12 | Cedars-Sinai Medical Center | Anti-methanogenic lovastatin analogs or derivatives and uses thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4915954A (en) * | 1987-09-03 | 1990-04-10 | Alza Corporation | Dosage form for delivering a drug at two different rates |
US5244916A (en) * | 1992-01-31 | 1993-09-14 | The Scripps Research Institute | Inhibition of respiratory burst using posttranslational modification inhibitors |
US5366738A (en) * | 1982-07-29 | 1994-11-22 | Merck & Co., Inc. | Controlled release drug dispersion delivery device |
US5518730A (en) * | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
US5582838A (en) * | 1994-12-22 | 1996-12-10 | Merck & Co., Inc. | Controlled release drug suspension delivery device |
US5616593A (en) * | 1993-10-29 | 1997-04-01 | Cadila Laboratories Limited | Compositions containing piperine |
-
2000
- 2000-11-03 NZ NZ518770A patent/NZ518770A/en not_active IP Right Cessation
- 2000-11-03 WO PCT/US2000/030415 patent/WO2001034123A1/en active IP Right Grant
- 2000-11-03 AU AU13607/01A patent/AU768950B2/en not_active Ceased
- 2000-11-03 CA CA002390301A patent/CA2390301A1/en not_active Abandoned
- 2000-11-03 IL IL14952400A patent/IL149524A0/en unknown
- 2000-11-03 GB GB0210619A patent/GB2371748B/en not_active Expired - Lifetime
- 2000-11-03 DE DE10085183T patent/DE10085183T1/en not_active Ceased
-
2003
- 2003-02-07 HK HK03100941A patent/HK1050134A1/en not_active IP Right Cessation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366738A (en) * | 1982-07-29 | 1994-11-22 | Merck & Co., Inc. | Controlled release drug dispersion delivery device |
US4915954A (en) * | 1987-09-03 | 1990-04-10 | Alza Corporation | Dosage form for delivering a drug at two different rates |
US5244916A (en) * | 1992-01-31 | 1993-09-14 | The Scripps Research Institute | Inhibition of respiratory burst using posttranslational modification inhibitors |
US5518730A (en) * | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
US5616593A (en) * | 1993-10-29 | 1997-04-01 | Cadila Laboratories Limited | Compositions containing piperine |
US5582838A (en) * | 1994-12-22 | 1996-12-10 | Merck & Co., Inc. | Controlled release drug suspension delivery device |
Also Published As
Publication number | Publication date |
---|---|
DE10085183T1 (en) | 2002-10-24 |
GB2371748A (en) | 2002-08-07 |
NZ518770A (en) | 2004-02-27 |
AU768950B2 (en) | 2004-01-08 |
WO2001034123A1 (en) | 2001-05-17 |
GB0210619D0 (en) | 2002-06-19 |
HK1050134A1 (en) | 2003-06-13 |
CA2390301A1 (en) | 2001-05-17 |
IL149524A0 (en) | 2002-11-10 |
AU1360701A (en) | 2001-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0104258A3 (en) | Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor | |
DK1223918T3 (en) | Pharmaceutical compositions comprising an HMG-CoA reductase inhibitor | |
PL359820A1 (en) | Hmg-coa reductase inhibitors and method | |
AU3368400A (en) | Aerosol compositions of hmg-coa reductase inhibitors for inhibiting inflammationassociated with pulmonary disease | |
PL355099A1 (en) | Pyrrole derivatives as phosphodiesterase vii inhibitors | |
AU1530001A (en) | Inhibitor compositions | |
EP1286702A4 (en) | HMG CoA REDUCTASE INHIBITORS FOR PROMOTING ANGIOGENESIS | |
AU2002310798A1 (en) | Pharmaceutical compositions comprising a hmg-coa reductase inhibitor | |
AU2003250172A1 (en) | Compositions comprising hmg-coa reductase inhibitor | |
HK1047276A1 (en) | Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors | |
IL132786A0 (en) | Hmg-coa reductase inhibitor preparation process | |
GB2371748B (en) | HMG-COA reductase inhibitor extended release formulation | |
AU4543699A (en) | Multibinding inhibitors of hmg-coa reductase | |
AU3235100A (en) | Prothease inhibitors | |
AU6589200A (en) | Extended release formulation of etodolac | |
AU2001280461A1 (en) | Substituted pyrrole compounds and their use as spla2 inhibitors | |
GB2389113B (en) | B-secretase inhibitor | |
AU3595900A (en) | Tyrosine alkoxyguanidines as integrin inhibitors | |
AU5762899A (en) | Caspase inhibitor | |
HUP0201597A3 (en) | Antilipemic combunations comprising hmg-coa reductase inhibitors and carnitines | |
HUP0105145A3 (en) | Process for producing hmg-coa reductase inhibitor | |
AU2001269121A1 (en) | Substituted amidoalkyl-uracils as parp inhibitors | |
HUP0301728A3 (en) | Hmg-coa reductase inhibiting pharmaceutical compositions and their use | |
GB9911546D0 (en) | Release of poorly soluble agents | |
AU2001228647A1 (en) | Dihydrofolate reductase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1050134 Country of ref document: HK |
|
PE20 | Patent expired after termination of 20 years |
Expiry date: 20201102 |